Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.0B | 5.4B | 5.2B |
Cost of revenue | 3.6B | 3.6B | 3.3B | 3.2B |
Gross profit | 2.4B | 2.4B | 2.1B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 451.7M | 496.4M | 413.6M | 364.0M |
Operating income | 1.1B | 1.1B | 882.4M | 852.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 24.5M | 27.9M | 35.7M | 37.9M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.2B | 1.1B | 1.1B |
Tax provision | 207.9M | 235.1M | 215.1M | 199.6M |
Net income | 1.0B | 1.0B | 919.9M | 865.9M |
Basic EPS | — | 7.2 | 6.6 | 6.2 |
Diluted EPS | — | 7.1 | 6.6 | 6.2 |
Basic average shares | — | 140.2M | 140.2M | 140.1M |
Diluted average shares | — | 140.4M | 140.4M | 140.3M |
EBITDA | 1.5B | 1.5B | 1.4B | 1.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |